Jayram Krishnan DO MBA

2.7K posts

Jayram Krishnan DO MBA banner
Jayram Krishnan DO MBA

Jayram Krishnan DO MBA

@AskDoctorJay

Summit Urology Katılım Haziran 2014
1.7K Takip Edilen1.7K Takipçiler
Jayram Krishnan DO MBA retweetledi
Urologic Oncology
Urologic Oncology@UrolOncol·
📢Published in the August issue of @UrolOncol! This study underscores the significant variability in postoperative care recommendations for RP and the urgent need for standardized, evidence-based guidelines. 🔗bit.ly/45IxGsQ
Urologic Oncology tweet media
English
0
6
12
1.2K
Jayram Krishnan DO MBA retweetledi
Advanced Prostate Cancer Consensus Conference
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano·
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials jamanetwork.com/journals/jaman… This cohort study analyzed individual patient data from the SPARTAN and TITAN phase 3 trials to examine the impact of statin exposure on outcomes in men with advanced #ProstateCancer treated with apalutamide. Among 2,187 patients, statin use was associated with significantly improved overall survival in apalutamide-treated patients but not in those receiving placebo, with 3-year survival differences of 14% in TITAN and 8% in SPARTAN favoring statin users. However, patients on statins also had a higher risk of grade 3 or greater cardiac adverse events, likely reflecting underlying cardiovascular comorbidities. These findings suggest that statin exposure may confer a survival benefit in the setting of intensified androgen blockade with apalutamide, though cardiovascular risks require careful consideration. @Soum_Roy_RadOnc @ziremozay @avirupguha @yilun_sun @WallisCJD @PBarataMD @AmarUKishan @angela_jia_ @NicholasZaorsky @umangtalking @scserendipity1 @DrSpratticus @neerajaiims @OncoAlert 🚨 @silkegillessen @AOmlin @nataliagandur @bavilima @yekeduz_emre
Advanced Prostate Cancer Consensus Conference tweet media
English
0
28
50
4.7K
Jayram Krishnan DO MBA retweetledi
Advanced Prostate Cancer Consensus Conference
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano·
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer jnccn.org/view/journals/… Article highlights that while #ProstateCancer (PCa) is the most common cancer among men in high-income countries, most men diagnosed with nonmetastatic PCa—especially those treated according to current NCCN Guidelines—are far more likely to die from causes other than their cancer. Using long-term, population-based data extending up to 30 years, the study found that men with nonmetastatic PCa were up to six times more likely to die of non-cancer causes, and even those with very high-risk disease and long life expectancy were still twice as likely to die of other causes. Findings underscore the importance of factoring in life expectancy and competing health risks when making treatment decisions, and they provide valuable benchmarks for clinicians when discussing outcomes and reporting results. @bratt_ola @OncoAlert 🚨 @silkegillessen @AOmlin @nataliagandur @bavilima @yekeduz_emre
Advanced Prostate Cancer Consensus Conference tweet media
English
2
16
26
2.9K
Jayram Krishnan DO MBA retweetledi
Advanced Prostate Cancer Consensus Conference
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano·
Magnetic Resonance Imaging–led Risk-adapted Active Surveillance for #ProstateCancer sciencedirect.com/science/articl… This large cohort study of 1150 men on MRI-led active surveillance (AS) for prostate cancer shows that MRI visibility and baseline Gleason pattern 4 strongly predict outcomes. With a median follow-up of 64 months, five-year event-free survival (EFS) was highest for men with nonvisible Gleason 3 + 3 disease (91%) and lowest for those with MRI-visible Gleason 3 + 4 disease (44%). Histological upgrade to Gleason ≥4 + 3 was uncommon (67 patients), and metastases occurred only in men who declined recommended MRI or biopsy follow-up. These findings support MRI-led AS as safe for most patients, while underscoring the prognostic importance of MRI visibility and Gleason pattern 4 in guiding risk stratification and monitoring intensity. @CEnglman @DavideMaffei_MD @VStavrinides @dougpendse @ShonitP @navinram999 @aimhaider @john_withington @Kazzawilk @veerukasi @EmbertonMark @giga_fra @mrsprostate @OncoAlert 🚨 @silkegillessen @AOmlin @nataliagandur @bavilima @yekeduz_emre
Advanced Prostate Cancer Consensus Conference tweet media
English
1
17
37
4K
Jayram Krishnan DO MBA retweetledi
Virtua Health
Virtua Health@VirtuaHealth·
A big milestone for such a small incision! Our surgeons at Virtua Our Lady of Lourdes Hospital just completed their 100th single-port robotic urologic procedure! This advanced technology empowers our team to perform complex urologic surgeries through just one small incision — helping patients recover faster with less pain. From all of us at Virtua, congrats on this amazing achievement!
Virtua Health tweet mediaVirtua Health tweet media
English
0
1
3
250
Jayram Krishnan DO MBA
Jayram Krishnan DO MBA@AskDoctorJay·
@DrShakuriRad Great video @DrShakuriRad STEP is a great way to approach large glands (my experience is 120gm to 380gm). I use a surgeon controlled suction such as ROSI and perform a circumferential anastomosis. ~80% of patients are same day discharge, no CBI and foley out in a week.
English
1
0
1
36
Jay Shakuri-Rad, DO, FACOS
Jay Shakuri-Rad, DO, FACOS@DrShakuriRad·
Intuitive SP Transvesical Enucleation of Prostate (STEP). Should multiport simple prostatectomy be a thing of the past? Can be done in 30-45min in supine position in most cases. Many options for BPH…which is best? #RoboticSurgery
English
4
1
26
1.2K

Keşfet

@NYCRoboticTeam @RoboticsUrology @MarcMercadante @UrolOncol @Soum_Roy_RadOnc @ziremozay @avirupguha @yilun_sun